Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified

Blood Cancer Journal

Volumn 4, Issue 11, 2014, Pages

  Laginestra, M A ^a   Piccaluga, P P ^a   Fuligni, F ^a   Rossi, M ^a   Agostinelli, C ^a   Righi, S ^a   Sapienza, M R ^a   Motta, G ^a   Gazzola, A ^a   Mannu, C ^a   Sabattini, E ^a   Bacci, E ^a   Tabanelli, V ^a   Sacchetti, C A S ^a   Barrese, T Z ^b   Etebari, M ^a   Melle, F ^a   Clo A ^a   Gibellini, D ^a   Tripodo, C ^c   Inghirami, G ^d   Croce, C M ^e   Pileri, S A ^a   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; RNA;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; BIOINFORMATICS; CD4 CD8 RATIO; DEREGULATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; MOLECULAR PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VALIDATION STUDY; BIOSYNTHESIS; CLINICAL TRIAL; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; METABOLISM; PROCEDURES;

FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, NEOPLASM;

EID: 84927939976     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2014.78     Document Type: Article

References (54)

1. Jaffe ES, Harris NL, Stein H, Campo E, Pileri SA, Swerdlow SH et al. Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn. IARC: Lyon, France, 2008, pp 158-166.
2. Dyer MJS, Siebert R. Peripheral T-cell non-Hodgkin's lymphoma NOS: naming of parts. Leukemia 2006; 20: 208-209.
3. Pileri SA, Weisenburger DD, Sng I, Jaffe ES, Ralfkiaer E, Nakamura S et al. Peripheral T-cell lymphoma, not otherwise specified. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn. IARC: Lyon, France, 2008, pp 306-308.
4. Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006; 24: 2472-2479.
5. Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol 2013; 16: 1970-1976.
6. Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol. 2007; 25: 3321-3329.
7. Piccaluga PP, Fuligni F, De Leo A, Bertuzzi C, Rossi M, Bacci F et al. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol 2013; 31: 3019-3025.
8. Roncolato F, Gazzola A, Zinzani PL, Pileri SA, Piccaluga PP. Targeted molecular therapy in peripheral T-cell lymphomas. Expert Rev Hematol 2011; 4: 551-562.
9. Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006; 20: 1533-1538.
10. Zettl A, Rudiger T, Konrad MA, Chott A, Simonitsch-Klupp I, Sonnen R et al. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004; 164: 1837-1848.
11. Feldman AL, Law M, Remstein ED, Macon WR, Erickson LA, Grogg KL et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 2009; 23: 574-580.
12. Thorns C, Bastian B, Pinkel D, Roydasgupta R, Fridlyand J, Merz H et al. Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach. Genes Chromosomes Cancer 2007; 46: 37-44.
13. Renedo M, Martinez-Delgado B, Arranz E, Garcia M J, Urioste M, Martinez-Ramirez A et al. Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia 2001; 10: 1627-1632.
14. Hartmann S, Gesk S, Scholtysik R, Kreuz M, Bug S, Vater I et al. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. Br J Haematol 2010; 148: 402-412.
15. Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20: 313-318.
16. Fujiwara S-I, Yamashita Y, Nakamura N, Choi Y L, Ueno T, Watanabe H et al. High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays. Leukemia 2008; 22: 1891-1898.
17. Martinez-Delgado B, Melendez B, Cuadros M, Alvarez J, Castrillo JM, Ruiz De La Parte A et al. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 2004; 10: 4971-4982.
18. Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007; 117: 823-834.
19. Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010; 28: 1583-1590.
20. Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115: 1026-1036.
21. De Leval L, Rickman DS, Thielen C, Reynies Ad, Huang YL, Delsol G et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952-4963.
22. Ballester B, Ramuz O, Gisselbrecht C, Doucet G, Loï L, Loriod B et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006; 25: 1560-1570.
23. Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 2014; 123: 2915-2923.
24. Agnelli L, Mereu E, Pellegrino E, Limongi T, Kwee I, Bergaggio E et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALKnegative anaplastic large-cell lymphoma. Blood 2012; 120: 1274-1281.
25. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
26. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261.
27. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers [letter]. Nature 2005; 435: 834-838.
28. Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK - anaplastic large-cell lymphoma. Proc Natl Acad Sci USA 2011; 107: 16228-16233.
29. Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, de Paiva GR et al. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 2011; 25: 1882-1890.
30. Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N et al. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 2011; 118: 6881-6892.
31. Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 2011; 117: 6627-6637.
32. Spaccarotella E, Pellegrino E, Ferracin M, Ferreri C, Cuccuru G, Liu C et al. STAT3-mediated activation of microRNA cluster 17 ~ 92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica 2014; 99: 116-124.
33. Yan Z-X, Wu L-L, Xue K, Zhang Q-L, Guo Y, Romero M et al. MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma. Leukemia 2014; 28: 880-887.
34. Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 2013; 122: 2083-2092.
35. April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J et al. Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PloS One 2009; 4: e8162.
36. Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J et al. Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay. J Pathol 2010; 221: 452-461.
37. Shirdel EA, Xie W, Mak TW, Jurisica I. NAViGaTing the micronome-using multiple microRNA prediction databases to identify signalling pathway-associated micro- RNAs. PLoS One 2011; 6: e17429.
38. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
39. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. JAMA 1958; 58: 457-481.
40. Piccaluga PP, Agostinelli C, Tripodo C, Gazzola A, Bacci F, Sabattini E et al. Peripheral T-cell lymphoma classification: the matter of cellular derivation. Expert Rev Hemat 2011; 4: 415-425.
41. Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007; 67: 10703-10710.
42. Wilcox RA, Sun DX, Novak A, Dogan A, Ansell SM, Feldman AL. Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non- Hodgkin's lymphoma cell lines. Leukemia 2010; 24: 229-232.
43. Savage KJ. Aggressive peripheral T-cell lymphomas (specified and unspecified types). Hematology Am Soc Hematol Educ Program 2005; 267-277.
44. Feldman AL, Sun DX, Law ME, Novak AJ, Attygalle AD, Thorland EC et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia 2008; 22: 1139-1143.
45. Pileri SA, Piccaluga PP. New molecular insights into peripheral T cell lymphomas. J Clin Invest 2012; 122: 3448-3455.
46. Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124-4130.
47. Zhao W-L. Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways. Leukemia 2010; 24: 13-21.
48. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120-130.
49. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122.
50. Suzuki H I, Matsuyama H, Noguchi M, Yao T, Komatsu N, Mano H et al. Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes [letter]. Leukemia 2013; 27: 2107-2111.
51. Wang W, Peng B, Wang D, Ma X, Jiang D, Zhao J et al. Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets. Int J Cancer 2011; 129: 1624-1634.
52. Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J et al. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 2011; 32: 1183-1189.
53. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, 4th edn. IARC: Lyon, France, 2008.
54. Federico M, Bellei M, Pesce EA, Zucca E, Pileri S, Montoto S et al. T-cell project: an international, prospective, observational study of patients with aggressive peripheral T-cell lymphoma-analysis of first 524 patients. Ann Oncol 2011; 22(Suppl. 4): iv164-iv167(abstract 241).